These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9454786)

  • 1. YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
    Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Yatsugi SI; Shimizu-Sasamata M; Koshiya K; Shishikura JI; Sakamoto S; Yamaguchi T
    J Pharmacol Exp Ther; 1998 Feb; 284(2):467-73. PubMed ID: 9454786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
    CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.
    Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Ichiki C; Yatsugi SI; Koshiya K; Shimizu-Sasamata M; Yamaguchi T
    J Pharmacol Exp Ther; 1998 Nov; 287(2):559-66. PubMed ID: 9808681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.
    Yatsugi S; Takahashi M; Kawasaki-Yatsugi S; Koshiya K; Sakamoto S; Uematsu D; Shimizu-Sasamata M
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):959-66. PubMed ID: 8784240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Takahashi M; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Neuropharmacology; 2000 Jan; 39(2):211-7. PubMed ID: 10670416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T
    J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats.
    Shimizu-Sasamata M; Kano T; Rogowska J; Wolf GL; Moskowitz MA; Lo EH
    Stroke; 1998 Oct; 29(10):2141-8. PubMed ID: 9756596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy.
    Hara H; Yamada N; Kodama M; Matsumoto Y; Wake Y; Kuroda S
    Eur J Pharmacol; 2006 Feb; 531(1-3):59-65. PubMed ID: 16403498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion.
    Håberg A; Takahashi M; Yamaguchi T; Hjelstuen M; Haraldseth O
    Brain Res; 1998 Nov; 811(1-2):63-70. PubMed ID: 9804894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
    Terai K; Suzuki M; Sasamata M; Yatsugi Si; Yamaguchi T; Miyata K
    Eur J Pharmacol; 2003 Apr; 467(1-3):95-101. PubMed ID: 12706461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spinal antinociceptive effects of a novel competitive AMPA receptor antagonist, YM872, on thermal or formalin-induced pain in rats.
    Nishiyama T; Gyermek L; Lee C; Kawasaki-Yatsugi S; Yamaguchi T
    Anesth Analg; 1999 Jul; 89(1):143-7. PubMed ID: 10389792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The systemically administered competitive AMPA receptor antagonist, YM872, has analgesic effects on thermal or formalin-induced pain in rats.
    Nishiyama T; Gyermek L; Lee C; Kawasaki-Yatsugi S; Yamaguchi T
    Anesth Analg; 1999 Dec; 89(6):1534-7. PubMed ID: 10589643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.
    Bullock R; Graham DI; Swanson S; McCulloch J
    J Cereb Blood Flow Metab; 1994 May; 14(3):466-71. PubMed ID: 8163588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats.
    Ni JW; Takahashi M; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
    Neuroreport; 1998 Nov; 9(16):3719-24. PubMed ID: 9858385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of a novel AMPA receptor antagonist, YM872.
    Small DL; Murray CL; Monette R; Kawasaki-Yatsugi S; Morley P
    Neuroreport; 1998 May; 9(7):1287-90. PubMed ID: 9631414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats.
    Akiho H; Iwai A; Tsukamoto S; Koshiya K; Yamaguchi T
    Neuropharmacology; 1998; 37(2):159-68. PubMed ID: 9680240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
    Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
    Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate AMPA receptor antagonist treatment for ischaemic stroke.
    Akins PT; Atkinson RP
    Curr Med Res Opin; 2002; 18 Suppl 2():s9-13. PubMed ID: 12365832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.